Indaptus Therapeutics, Inc.
INDP· Nasdaq
Released Mar 13, 2024, before the open
10-K filed Mar 13, 2024, 73 days after period end · 0001493152-24-009769
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$4.00M | -$3.66M | -$3.22M | -$770.22K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2023 · filed Mar 13, 2024 · 73 d after period end
4.8% from the close of Mar 12, 2024 to the close of Mar 13, 2024, the first after the release.